Clinical Trials
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
SHOW-ME-PAD (Peripheral Artery Disease)
- Ages18 years - 90 years
- GenderBoth
- Heart/Cardiovascular
SCOPE-CLI: Shifting Care and Outcomes for Patients with Endangered limbs Critical Limb Ischemia
- Ages19 years and older
- GenderBoth
- Heart/Cardiovascular
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- Ages18 years - 95 years
- GenderBoth
- Heart/Cardiovascular
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD)
- Ages18 years and older
- GenderFemale only
- Aging, Heart/Cardiovascular, Brain, Spinal Cord & Nervous System
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)
- Ages75 years and older
- GenderBoth
- Heart/Cardiovascular, Kidney & Urinary Tract
Ellipsys Vascular Access System Post Market Surveillance (PS) Study
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular
Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS)
- Ages18 years and older
- GenderBoth